Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy

Publication date

2016-12-01

Authors

Bourfiss, Mimount
te Riele, Anneline S. J. M.
Mast, Thomas P.
Cramer, Maarten JISNI 0000000390984527
van der Heijden, Jeroen FISNI 0000000396634202
van Veen, ToonISNI 0000000394849488
Loh, PeterISNI 0000000357477339
Dooijes, DennisISNI 0000000389750790
Hauer, Richard N. W.
Velthuis, BirgittaORCID 0000-0002-2542-9474ISNI 0000000395231874

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

taverne

Abstract

INTRODUCTION: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) is associated with desmosomal mutations. Although desmosomal disruption affects both ventricles and atria, little is known about atrial involvement in ARVD/C. OBJECTIVE: To describe the extent and clinical significance of structural atrial involvement and atrial arrhythmias (AA) in ARVD/C stratified by genotype. METHODS: We included 71 patients who met ARVD/C Task Force Criteria and underwent Cardiac Magnetic Resonance (CMR) imaging and molecular genetic analysis. Indexed atrial end-diastolic volume and area-length-ejection-fraction (ALEF) were evaluated on CMR and compared to controls with idiopathic right ventricular outflow tract tachycardia (n = 40). The primary outcome was occurrence of AA (atrial fibrillation or atrial flutter) during follow-up, recorded by 12-lead ECG, Holter monitoring or implantable cardioverter defibrillator (ICD) interrogation. RESULTS: Patients harbored a desmosomal Plakophilin-2 (PKP2)(n = 37) or non-desmosomal Phospholamban (PLN) (n = 14) mutation. In 20 subjects, no pathogenic mutation was identified. Compared to controls, right atrial (RA) volumes were reduced in PKP2 (p = 0.002) and comparable in PLN (p = 0.441) mutation carriers. In patients with no mutation identified, RA (p = 0.011) and left atrial (p = 0.034) volumes were increased. Bi-atrial ALEF showed no significant difference between the groups. AA were experienced by 27% of patients and occurred equally among PKP2 (30%) and no mutation identified patients (30%), but less among PLN mutation carriers (14%). CONCLUSION: Genotype influences atrial volume and occurrence of AA in ARVD/C. While the incidence of AA is similar in PKP2 mutation carriers and patients with no mutation identified, PKP2 mutation carriers have significantly smaller atria. This suggests a different arrhythmogenic mechanism. This article is protected by copyright. All rights reserved.

Keywords

arrhythmogenic right ventricular dysplasia, atria, atrial fibrillation, cardiac magnetic resonance imaging, cardiomyopathy, genotype, Taverne, Cardiology and Cardiovascular Medicine, Physiology (medical), Journal Article

Citation

Bourfiss, M, Te Riele, A S J M, Mast, TP, Cramer, M J, Van Der Heijden, J F, Van Veen, T A B, Loh, KP, Dooijes, D, Hauer, RNW & Velthuis, B K 2016, 'Influence of Genotype on Structural Atrial Abnormalities and Atrial Fibrillation or Flutter in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy', Journal of Cardiovascular Electrophysiology, vol. 27, no. 12, pp. 1420-1428. https://doi.org/10.1111/jce.13094